According to the new market research report by MarketsandMarkets, [185 Pages Report] The global HLA typing market is projected to reach USD 1.7 billion by 2025 from USD 1.2 billion in 2019, at a CAGR of 5.9%.
Growth in the HLA typing market is mainly driven by factors such as the increasing number of HLA typing procedures conducted, technological advancements in the field of HLA typing, and increasing funding for research. However, the high costs of HLA typing products and limited reimbursements for target procedures are expected to restrain market growth in the coming years. Along with this, the significant supply-demand gap between the number of organ donors and organs required annually is expected to challenge market growth to a certain extent.
What is the expected addressable market value of major HLA typing market products over a 5-year period?
Based on the prevailing trends and estimated market value data as of 2019, the total market value of major HLA typing products is estimated to be about USD 1.7 billion as of 2025.
Which product categories are expected to have highest growth rate in the HLA typing market?
The reagents & consumables segment accounted for the largest share of 71.8% of the HLA typing market in 2018. This segment is also projected to register the highest CAGR during the forecast period (2019-2024). Their demand growth is mainly driven by increased prevalence of related injuries (such as ACL & spinal procedures), utilization of target products among sports person for preventive care, and rising sales through off-the-shelf channel.
Download PDF Brochure: www.marketsandmarkets.com/pdfdownloadNew.asp?id=39129877
What are the opportunistic areas are available for new and existing players in the HLA typing market to enhance their market share?
Rising adoption of cross-matching and chimerism testing and increasing public awareness about transplantation are some of the key opportunistic areas available for the emerging as well as established players in the market.
What are the major revenue pockets in the HLA typing market currently?
North America accounted for the largest share of 45.0% (with US garnering the most of 94.3%) of the HLA typing market in 2018. This is majorly attributed to the high adoption of advanced diagnostic technologies, increasing prevalence of target diseases in the US and Canada, and technological advancements. The rising geriatric population and growing funding and support for research are other major factors driving the growth of this regional segment.
Request for Sample Pages: www.marketsandmarkets.com/requestsampleNew.asp?id=39129877
Leading Key Players
Thermo Fisher Scientific Inc. (US), Bio-Rad Laboratories, Inc. (US), F. Hoffman-La Roche Ltd. (Switzerland), QIAGEN N.V. (Netherlands), Illumina, Inc. (US), Immucor, Inc. (US), CareDx (US), Becton, Dickinson and Company (US), Hologic (US), GenDx (Netherlands), and Biofortuna (UK) are the players in this market.